600 related articles for article (PubMed ID: 18949355)
1. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
[TBL] [Abstract][Full Text] [Related]
2. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
3. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
[TBL] [Abstract][Full Text] [Related]
4. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
[TBL] [Abstract][Full Text] [Related]
5. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
Jiang Q; Wei H; Tian Z
BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
[TBL] [Abstract][Full Text] [Related]
6. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
[TBL] [Abstract][Full Text] [Related]
7. Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells.
Guo Z; Chen L; Zhu Y; Zhang Y; He S; Qin J; Tang X; Zhou J; Wei Y
Oncol Rep; 2012 Feb; 27(2):396-402. PubMed ID: 22075935
[TBL] [Abstract][Full Text] [Related]
8. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G
J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T
Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664
[TBL] [Abstract][Full Text] [Related]
10. TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells.
Chen L; Xu YY; Zhou JM; Wu YY; E Q; Zhu YY
Oncol Rep; 2012 Jul; 28(1):200-6. PubMed ID: 22552584
[TBL] [Abstract][Full Text] [Related]
11. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
[TBL] [Abstract][Full Text] [Related]
12. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
14. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways.
Dogusan Z; García M; Flamez D; Alexopoulou L; Goldman M; Gysemans C; Mathieu C; Libert C; Eizirik DL; Rasschaert J
Diabetes; 2008 May; 57(5):1236-45. PubMed ID: 18223009
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 3 ligand-induced antiviral response in mouse osteoblastic cells.
Nakamura K; Deyama Y; Yoshimura Y; Suzuki K; Morita M
Int J Mol Med; 2007 May; 19(5):771-5. PubMed ID: 17390082
[TBL] [Abstract][Full Text] [Related]
16. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
Salaun B; Lebecque S; Matikainen S; Rimoldi D; Romero P
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4565-74. PubMed ID: 17671143
[TBL] [Abstract][Full Text] [Related]
18. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages.
Huang SH; Cao XJ; Wei W
J Pineal Res; 2008 Aug; 45(1):93-100. PubMed ID: 18312297
[TBL] [Abstract][Full Text] [Related]
19. Expression of functional CD40 in human hepatocellular carcinoma.
Sugimoto K; Shiraki K; Ito T; Fujikawa K; Takase K; Tameda Y; Moriyama M; Nakano T
Hepatology; 1999 Oct; 30(4):920-6. PubMed ID: 10498643
[TBL] [Abstract][Full Text] [Related]
20. TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis.
Taura M; Fukuda R; Suico MA; Eguma A; Koga T; Shuto T; Sato T; Morino-Koga S; Kai H
Cancer Sci; 2010 Jul; 101(7):1610-7. PubMed ID: 20367642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
